Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Ross JS, Madigan D, Konstam MA, Egilman DS, Krumholz HM. Persistence of Cardiovascular Risk After Rofecoxib Discontinuation. JAMA Internal Medicine 2010, 170: 2035-2036. PMID: 21149763, PMCID: PMC3024905, DOI: 10.1001/archinternmed.2010.461.Peer-Reviewed Original Research